Mar 2, 2020
LensGen is a clinical stage company headquartered in Irvine,
California focused on restoring youthful vision to millions of
cataract and presbyopia patients. With its innovative Juvene™
modular fluid optic intraocular lens the company aims to treat
vision correction errors and provide spectacle independence to
patients affected by cataracts and/or presbyopia. Their
leader is a serial entrepreneur with 25 years of experience in
the ophthalmic pharmaceutical and device industry. What are
some of the key strategic insights to scaling a startup to a large
scale medtech organization?
In this episode of DeviceAlliance’s Medtech Radio, we speak with
the CEO of Lensgen, Inc., Ramgopal Rao. Ram is the Inventor,
Founder, and Chief Executive Officer of LensGen, Inc., a
clinical-stage medical device company that is developing a novel
intraocular lens for presbyopia. Currently, he is also
Chairman of the Board of 2C Tech Corporation, Inc., an emerging
medical device company that is developing a novel nanotechnology
application for preservation of vision for patients with
degenerative retinal diseases. Join us as we discuss his
journey as a medtech founder as he shares his insights on
understanding the long game, the role of clinical innovators &
investors, the difference between money and smart money, and
embracing your entrepreneurial passion.